MASH Therapies: Approved Drug or Real-World Data

Nov 09 2025
Convention Center: Ballroom A, Level 3
5:00 PM - 6:30 PM

World Class Speakers

Robert M Wilechansky, MD
Moderator

Robert M Wilechansky, MD

Oregon Health & Science University
Philip N Newsome, MD, PhD
Moderator

Philip N Newsome, MD, PhD

King's College London

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Objectives

  • Review efficacy and safety data from ongoing clinical trials of approved drugs for MASH, highlighting emerging evidence and remaining gaps.
  • Discuss challenges and insights from implementing approved MASH treatments, as well as weight loss medications, bariatric surgeries, and endoscopic procedures, in routine clinical practice. Presenters will also address issues related to patient selection and monitoring.